Radical Stereotactic Radiosurgery for Small Lung Tumors
Author Information
Author(s): Brian T Collins, Kelly Erickson, Cristina A Reichner, Sean P Collins, Gregory J Gagnon, Sonja Dieterich, Don A McRae, Ying Zhang, Shadi Yousefi, Elliot Levy, Thomas Chang, Carlos Jamis-Dow, Filip Banovac, Eric D Anderson
Primary Institution: Georgetown University Hospital
Hypothesis
Can stereotactic radiosurgery with real-time tumor motion tracking effectively treat small peripheral lung tumors?
Conclusion
This treatment option is promising and well-tolerated for small peripheral lung tumors.
Supporting Evidence
- All tumors responded to treatment at 3 months.
- The crude survival rate was 83% at a median follow-up of 12 months.
- No procedure-related mortalities were reported.
- Grade III pneumonitis occurred in 2 patients, both of whom recovered.
Takeaway
Doctors used a special technique to treat small lung tumors with radiation while tracking their movement, and it worked well with few side effects.
Methodology
Patients were treated with stereotactic radiosurgery using real-time tumor motion tracking and followed for at least 6 months.
Limitations
The study had a small sample size and limited follow-up duration.
Participant Demographics
The study included 10 men and 14 women, with a median age of 70 years.
Statistical Information
P-Value
0.002 for DLCO at 6 months; 0.01 for DLCO at 12 months
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website